Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The most common PCOS type in adolescents is hyperandrogenic with polycystic ovaries.

TMPRSS6 is crucial for controlling hepcidin and normal iron absorption.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

Oral zinc gluconate and topical steroids significantly improved a rare scalp condition in three elderly patients.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requiring high doses of calcium and vitamin D for treatment.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS and suggest the need for further tests for related health issues.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Pellagrous dermatitis, caused by niacin deficiency, can be cured with vitamin supplements.

The condition is linked to chromosome 12, but no mutations were found in the known genes.

PCOS is a common disorder in women causing hormonal imbalance and fertility issues, often managed with lifestyle changes and medication.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

The document concludes that specific hair and blood vessel abnormalities in infants with seizures and developmental issues may indicate Menkes disease, which lacks a cure and is often fatal by age 3.

5α-reductases increase epitestosterone's effect on androgen receptors.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.